Oklahoma Officials Link 7-OH Kratom Compound to 50+ Deaths, Call on Retailers to Pull Products

Why it matters

More than 50 kratom-related deaths in Oklahoma since January 2025 — including 14 in Tulsa County alone — show that the 7-OH crisis is no longer confined to coastal markets; it is a documented, accelerating public health emergency in the American heartland.

The big picture

Oklahoma's Kratom Consumer Protection Act (Senate Bill 891), effective November 2025, caps the potency of kratom sold in the state and restricts 7-OH concentration levels. However, because 7-OH is not yet classified as a controlled substance in Oklahoma, the Bureau of Narcotics currently lacks jurisdiction to prosecute retailers. The Oklahoma toxicologist Dr. Kacey Cliburn noted her office only began seeing significant 7-OH cases in late 2025, and the numbers have climbed sharply. The most common compound being found in autopsies is dihydro-7-hydroxymitragynine (MGM-15) — one of the three synthetic alkaloids the DEA also targeted in its July 1 federal Notices of Intent.

Key findings

• Over 50 kratom-related deaths detected statewide between January 2025 and June 2026, including 14 in Tulsa County
• Most common autopsy finding: dihydro-7-hydroxymitragynine (MGM-15), not natural mitragynine
• 7-OH products sold in tablets scored into four sections — each tablet can contain 16 individual doses, making accidental overdose easy
• Oklahoma BN director says agency plans to work with legislators to classify concentrated 7-OH as Schedule I when session begins February 2027
• Federal temporary scheduling order can take effect no earlier than August 5, 2026; 7-OH remains federally legal until then

What they say

"Just because it's sold in a gas station, it might even be labeled as an all-natural product. There are certain types of kratom that are absolutely deadly and incredibly addictive." — Mark Woodward, Oklahoma Bureau of Narcotics

Bottom line

Oklahoma's rapidly rising 7-OH death toll and the dominance of MGM-15 in autopsies demonstrate that the synthetic kratom derivatives targeted by federal scheduling are already driving lethal outcomes in states with existing consumer protection laws.